MORE►
biotech
Cait Brumme CEO of MassChallenge. [Photo: MassChallenge]
The Last Word: MassChallenge CEO on INNOVATE ’25 and Looking Ahead at Forces Shaping Economies
by Quincy Preston | Nov 5, 2025
Cait Brumme says the event at Dallas' Pegasus Park on Nov. 6 will explore the technologies and economic forces defining the future for entrepreneurs and innovators.
by Quincy Preston |
Nov 4, 2025
The de-extinction startup is adding more than two decades of commercial cloning expertise to its portfolio with its first acquisition.
Days before the announcement, CEO Ben Lamm laid out his playbook at Venture Dallas 2025: run toward critics, treat promises to middle-America classrooms as seriously as commitments to investors—and spin out businesses worth more than $100 million.
MORE►
by David Seeley |
Oct 23, 2025
The Palo Alto-based company's new Dallas facility is its first dedicated U.S. laboratory, and will serve as its U.S. clinical operations headquarters. Overture's AI-driven IVF technology gives fertility teams "objective data to inform embryo selection without a biopsy," the company said, "allowing clinics to process three times the number of procedures without adding staff."
MORE►
by Quincy Preston |
Oct 14, 2025
The North Texas biotech, which uses AI to accelerate cancer drug development, received FDA feedback to advance a new clinical study targeting a rare childhood brain tumor.
MORE►
John Crowley, CEO of the Biotechnology Innovation Organization; Texas State Sen. Tan Parker; and Victoria Ford, CEO of the Texas Healthcare and Bioscience Institute, were among the voices shaping the conversation at the 2025 BioNTX iC3 Summit in Dallas. [Photos: Courtesy/BioNTX]
‘The Model is Broken’: From North Texas, a National Call to Action for Biotech’s Future
by Glenn Hunter | Sep 24, 2025
At Dallas’ iC3 Summit, leaders from Texas and across the U.S. pointed to AI, new state initiatives like Proposition 14, and potential federal reforms as keys to speeding innovation and keeping America competitive in life sciences.
MORE►
by Lance Murray |
Aug 28, 2025
The Pittsburgh-headquartered nonprofit's executive director, Dallas-based Gina Ford, takes up the newly created top post of the organization, which empowers women across biotech, pharma, and life sciences to lead, engage, and grow at every career stage.
MORE►
by Quincy Preston |
Jul 15, 2025
North Texas' Nanoscope just filed an FDA bid for its gene-agnostic therapy. If approved, it could help restore sight for people with inherited blindness, and potentially millions more with other retinal diseases.
MORE►
by David Seeley |
Jul 15, 2025
The California-based clinical-stage biotech startup is developing therapies to treat serious immunological diseases like atopic dermatitis and vitiligo.
MORE►
Signify Bio co-founders, from left: CEO R.A. Session II and Chief Scientific Officer Daniel Siegwart, Ph.D., of UT Southwestern. {Photos: Taysha Gene Therapies/UTSW]
Dallas’ Signify Bio Launches With Oversubscribed $15M Financing, Partnership With UT Southwestern
by Lance Murray | Jun 5, 2025
Co-founded by Chief Scientific Advisor Daniel J. Siegwart of UT Southwestern and CEO RA Session II, Signify Bio said it harnesses the human body for the production of in situ protein therapeutics. The round was led by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, and BrightEdge, the American Cancer Society's VC arm.
MORE►
by Lance Murray |
May 8, 2025
Eric Matthews will provide strategic leadership to biopharma business development, and through his executive leadership, support Caris' expanding portfolio of biopharma partnerships, the company said.
MORE►
by Quincy Preston |
Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
MORE►
by Lance Murray |
Apr 8, 2025
With the new funding, Caris said it has raised $1.86 billion in capital since 2018. Caris will use the raise to bring its science and technologies "to as many patients as possible and further our goal of revolutionizing precision medicine," Founder and CEO David Halbert said.
MORE►
Left to right: Eido Bio founders Courtney Rutkowski, Sara Chumbley, and Stephanie Collins [Photos: Eido Bio]
This Biopharma Trio Is Tackling the Blind Spots in Women’s Health
by Nicole Ward, DRC Data Journalist | Mar 27, 2025
Eido Bio’s three co-founders are taking on menopause, research gaps, and a market where women’s health “sort of starts and stops with birth control.” The biotech startup is raising a Series A to launch clinical trials for a menopause treatment—and help shift the science toward women.
MORE►
by Quincy Preston |
Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE►
by Lance Murray |
Jan 9, 2025
Virbac said that URSOLYX Soft Chews target mRNA expression in skeletal muscle, harnessing the proven benefits of ursolic acid to enhance muscle function and strength in aging, active, or recovering dogs.
MORE►
by Glenn Hunter |
Oct 24, 2024
Fundraising has slowed and valuations are down, but biotech founders could have a lifeline in family office investments, panelists at the recent BioNTX summit in Arlington agreed. They said succeeding with these investors can take time, a lot of education, and a compelling, well-crafted story that connects emotionally with the family.
MORE►
![Erica Kosemund, Chief Brand Officer, Choctaw Nation of Oklahoma; Gillian Breidenbach, Chief Partnership Officer, North Texas FWC Organizing Committee; Chief Gary Batton, Chief of Choctaw Nation of Oklahoma; Monica Paul, Executive Director of Dallas Sports Commission and President of North Texas FWC Organizing Committee; John Hobbs, Senior Executive Officer of Communications, Choctaw Nation of Oklahoma; and Heidi Grant, Senior Executive Officer of Commerce Administration, Choctaw Nation of Oklahoma, celebrate Choctaw Casinos & Resorts becoming an Official Dallas World Cup 2026 Host City Supporter. [Photo: North Texas FWC Organizing Committee/Choctaw Casinos & Resorts]](https://s24806.pcdn.co/wp-content/uploads/2025/12/FIFA-Choctaw-dec-2025.jpg)
